Ponesimod-d4 (ACT-128800-d4) is the deuterium labeled Ponesimod (HY-10569)[1]. Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation[2][3][4].
Molecular Weight:
465.00
Formula:
C23H21D4ClN2O4S
Target:
Isotope-Labeled Compounds,LPL Receptor
Application Notes:
Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
